Direct Evidence of Target Inhibition with Anti-VEGF, EGFR, and mTOR Therapies in a Clinical Model of Wound HealingJingquan Jia, Andrew B. Nixon, Andrew Dellinger et al.|Clinical Cancer Research|2015Cited by 5
Supplemental Figure 1 from Direct Evidence of Target Inhibition with Anti-VEGF, EGFR, and mTOR Therapies in a Clinical Model of Wound HealingJingquan Jia, Andrew B. Nixon, Christel Rushing et al.|Unknown|2023Cited by 0
Supplemental Table 3 from Direct Evidence of Target Inhibition with Anti-VEGF, EGFR, and mTOR Therapies in a Clinical Model of Wound HealingJingquan Jia, Andrew B. Nixon, Andrew Dellinger et al.|Unknown|2023Cited by 0
Supplemental Table 2 from Direct Evidence of Target Inhibition with Anti-VEGF, EGFR, and mTOR Therapies in a Clinical Model of Wound HealingJingquan Jia, Andrew B. Nixon, Andrew Dellinger et al.|Unknown|2023Cited by 0
Supplemental Table 1 from Direct Evidence of Target Inhibition with Anti-VEGF, EGFR, and mTOR Therapies in a Clinical Model of Wound HealingJingquan Jia, Andrew B. Nixon, Andrew Dellinger et al.|Unknown|2023Cited by 0